Aytu Biopharma, Inc: Form 8-K, filed Jun 25, 2026
Filed with the SEC on Jun 25, 2026 and accepted by EDGAR at Jun 25, 2026, 16:31 ET.
Items reported
- Item 1.02 Termination of a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001437749-26-021707. Last ingested by Listed: Oct 27, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.